Roche's Genentech Doubles Investment in North Carolina Biomanufacturing Site
Genentech increases its investment in a North Carolina facility to $2 billion, aiming to create over 2,000 jobs and produce obesity treatments by 2029.
Topic
Latest reporting and analysis tagged with biomanufacturing.
Genentech increases its investment in a North Carolina facility to $2 billion, aiming to create over 2,000 jobs and produce obesity treatments by 2029.